By Scientia Professor Carla Treloar

Journal articles

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; Group OBOTEES, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', International Journal of Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4

Djordjevic F; Ryan K; Gunn J; Brener L; O’Keefe D; Draper B; Schroeder S; Gold J; Treloar C; Broady T; Dietze P; Hellard M; Pedrana A, 2021, 'Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia', Journal of Viral Hepatitis, 28, pp. 1738 - 1743, http://dx.doi.org/10.1111/jvh.13612

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379

Walker S; Wallace J; Latham N; Saich F; Pedrana A; Hellard M; Treloar C; Marukutira T; Higgs P; Doyle J; Stoové M, 2021, '“It's time!”: A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103280

Cama E; Brener L; Broady T; Hopwood M; Treloar C, 2021, 'Australian health and medical workers’ concerns around providing care to people living with hepatitis B', Health and Social Care in the Community, 29, pp. e431 - e439, http://dx.doi.org/10.1111/hsc.13368

Brener L; Broady T; Cama E; Hopwood M; Byrne J; Treloar C, 2021, 'Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103323

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477

Kelly PJ; Beck AK; Deane FP; Larance B; Baker AL; Hides L; Manning V; Shakeshaft A; Neale J; Kelly JF; Oldmeadow C; Searles A; Palazzi K; Lawson K; Treloar C; Gray RM; Argent A; McGlaughlin R, 2021, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in SMART recovery mutual support groups: Stage 1 mixed methods pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/25217

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421

Broady TR; Brener L; Vuong T; Cama E; Treloar C, 2021, 'Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103292

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103261

Treloar C; Hopwood M; Drysdale K; Lea T; Holt M; Dowsett GW; Aggleton P; Bryant J, 2021, 'Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103229

Bryant J; Bolt R; Botfield JR; Martin K; Doyle M; Murphy D; Graham S; Newman CE; Bell S; Treloar C; Browne AJ; Aggleton P, 2021, 'Beyond deficit: ‘strengths-based approaches’ in Indigenous health research', Sociology of Health and Illness, 43, pp. 1405 - 1421, http://dx.doi.org/10.1111/1467-9566.13311

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore G; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571

Stardust Z; Treloar C; Cama E; Kim J, 2021, '‘I Wouldn’t call the cops if i was being bashed to death’: Sex work, whore stigma and the criminal legal system', International Journal for Crime Justice and Social Democracy, 10, http://dx.doi.org/10.5204/IJCJSD.1894

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277

Drysdale K; Bryant J; Dowsett GW; Lea T; Treloar C; Aggleton P; Holt M, 2021, 'Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex.', Int J Drug Policy, 93, pp. 103163 - 103163, http://dx.doi.org/10.1016/j.drugpo.2021.103163

Madden A; Lancaster K; Ritter A; Treloar C, 2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, 87, pp. 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014

Miller K; Treloar C; Lloyd AR, 2021, 'People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?', Addiction Research and Theory, 29, pp. 247 - 254, http://dx.doi.org/10.1080/16066359.2021.1879058

Treloar C; Stardust Z; Cama E; Kim J, 2021, 'Rethinking the relationship between sex work, mental health and stigma: a qualitative study of sex workers in Australia', Social Science and Medicine, 268, http://dx.doi.org/10.1016/j.socscimed.2020.113468

Marshall AD; Hopwood M; Grebely J; Treloar C, 2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, 86, http://dx.doi.org/10.1016/j.drugpo.2020.102964

Reilly R; Gendera S; Treloar C; Roe Y; Conigrave K; Azzopardi P; Ward J, 2020, 'Identifying risk and protective factors, including culture and identity, for methamphetamine use in Aboriginal and Torres Strait Islander communities: Relevance of the ‘communities that care’ model', Social Science and Medicine, 266, http://dx.doi.org/10.1016/j.socscimed.2020.113451

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', Plos One, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106

Broady TR; Brener L; Hopwood M; Cama E; Treloar C; Holt M, 2020, 'HIV stigma by association among Australian gay and bisexual men.', AIDS, 34 Suppl 1, pp. S53 - S62, http://dx.doi.org/10.1097/QAD.0000000000002565

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Brener L; Broady T; Cama E; Hopwood M; de Wit JBF; Treloar C, 2020, 'The role of social support in moderating the relationship between HIV centrality, internalised stigma and psychological distress for people living with HIV', AIDS Care Psychological and Socio Medical Aspects of AIDS HIV, 32, pp. 850 - 857, http://dx.doi.org/10.1080/09540121.2019.1659914

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', Jmir Research Protocols, 9, http://dx.doi.org/10.2196/15113

Drysdale K; Bryant J; Holt M; Hopwood M; Dowsett GW; Aggleton P; Lea T; Treloar C, 2020, 'Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use', International Journal of Drug Policy, 78, pp. 102697, http://dx.doi.org/10.1016/j.drugpo.2020.102697

Broady TR; Brener L; Cama E; Hopwood M; Treloar C, 2020, 'Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population', Plos One, 15, pp. e0232218, http://dx.doi.org/10.1371/journal.pone.0232218

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Hajarizadeh B; Ezard N; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Hopwood M; Cama E; de Wit J; Treloar C, 2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536

Gray R; Kelly PJ; Beck AK; Baker AL; Deane FP; Neale J; Treloar C; Hides L; Manning V; Shakeshaft A; Kelly J; Argent A; McGlaughlin R, 2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144

Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs Education Prevention and Policy, 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170

Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705

Stoové M; Wallace J; Higgs P; Pedrana A; Goutzamanis S; Latham N; Scott N; Treloar C; Crawford S; Doyle J; Hellard M, 2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004

Dore G; Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Mcmanus H; Butler T; Vickerman P; Martin N; Mchutchison J; Brainard D; Treloar C; Lloyd A, 2020, 'LBP07 Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', Journal of Hepatology, 73, pp. s127, http://dx.doi.org/10.1016/s0168-8278(20)30769-8

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs Education Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C, 2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016

Bryant J; Rance J; Hull P; Mao L; Treloar C, 2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002

Walker M; Beadman K; Griffin S; Beadman M; Treloar C, 2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, 16, http://dx.doi.org/10.1186/s12954-019-0325-3

Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112

Rhodes T; Lancaster K; Harris M; Treloar C, 2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475

Brener L; Cama E; Broady T; Hopwood M; de Wit J; Treloar C, 2019, 'Predictors of health care workers’ support for discriminatory treatment and care of people who inject drugs', Psychology Health and Medicine, 24, pp. 439 - 445, http://dx.doi.org/10.1080/13548506.2018.1546018

Back to profile page